The contribution of suilysin to the pathogenesis of Streptococcus suis meningitis

Dan Takeuchi1, Yukihiro Akeda, Tatsuya Nakayama

  • 1Laboratory for Clinical Research on Infectious Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University.

Abstract

Insights

Suilysin production differs between Streptococcus suis strains, explaining why ST1 causes meningitis more often than ST104. Higher suilysin levels in ST1 strains increase inflammation and mortality in meningitis models.

Area of Science:

  • Microbiology
  • Pathogenomics
  • Zoonotic Diseases

Background:

  • Streptococcus suis is an emerging zoonotic pathogen causing sepsis and meningitis in humans.
  • Sequence type (ST) 1 and ST104 strains exhibit differential pathogenicity, with ST1 commonly causing meningitis.

Purpose of the Study:

  • Investigate the role of suilysin in the differential pathogenicity between ST1 and ST104 Streptococcus suis strains.
  • Determine how suilysin production impacts meningitis development.

Main Methods:

  • Compared sly gene transcription and translation in ST1 and ST104 strains using qPCR and Western blotting.
  • Assessed survival rates and brain bacterial densities in mice infected with wild-type and sly-knockout ST1 strains.
  • Evaluated ST104 infections with and without suilysin complementation.

Main Results:

  • ST1 strains produced significantly higher amounts of suilysin compared to ST104 strains.
  • Attenuated sly gene expression, linked to promoter insertions, caused lower suilysin production in ST104.
  • Suilysin contributed to increased bacterial density, brain inflammation, and mortality in a meningitis model.

Conclusions:

  • Suilysin production levels explain the differential meningitis causation by ST1 versus ST104 Streptococcus suis strains.
  • Suilysin is a key factor in the pathogenesis of Streptococcus suis meningitis in humans.